VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
HSICHenry Schein, Inc.
$79.92$9.2B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. HSIC
  3. Financial Ratios

Henry Schein, Inc. (HSIC) Financial Ratios

30 years of historical data (1996–2025) · Healthcare · Medical - Distribution

View Quarterly Ratios →

P/E Ratio
↑
24.44
+13% vs avg
5yr avg: 21.64
089%ile100
30Y Low10.6·High65.1
View P/E History →
EV/EBITDA
↑
11.88
+1% vs avg
5yr avg: 11.72
068%ile100
30Y Low5.1·High96.3
P/FCF
↓
16.00
↓-18% vs avg
5yr avg: 19.44
038%ile100
30Y Low7.9·High28.3
P/B Ratio
↓
2.03
-3% vs avg
5yr avg: 2.09
030%ile100
30Y Low1.5·High23.5
ROE
↓
8.3%
-17% vs avg
5yr avg: 10.0%
017%ile100
30Y Low-0%·High15%
Debt/EBITDA
↑
3.45
↑+49% vs avg
5yr avg: 2.31
0100%ile100
30Y Low0.5·High3.4

Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.

HSIC Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

Henry Schein, Inc. trades at 24.4x earnings, 13% above its 5-year average of 21.6x, sitting at the 89th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 10%. On a free-cash-flow basis, the stock trades at 16.0x P/FCF, 18% below the 5-year average of 19.4x.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$9.2B$9.3B$9.0B$10.0B$11.0B$11.0B$9.6B$10.0B$9.5B$8.7B$9.7B
Enterprise Value$12.7B$12.8B$11.7B$12.5B$12.4B$12.1B$10.2B$10.9B$11.3B$10.2B$10.8B
P/E Ratio →24.4423.2823.0923.9620.4317.4223.8819.6217.6521.3319.07
P/S Ratio0.700.700.710.810.870.890.951.000.720.700.83
P/B Ratio2.031.931.861.942.362.352.222.542.462.372.83
P/FCF16.0016.1713.6128.2621.7417.4317.4317.2315.9318.6917.72
P/OCF12.8813.0110.6119.9518.2815.4916.0115.2213.8215.9015.70

P/E links to full P/E history page with 30-year chart

HSIC EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

Henry Schein, Inc.'s enterprise value stands at 11.9x EBITDA, roughly in line with its 5-year average of 11.7x. The Healthcare sector median is 14.2x, placing the stock at a 16% discount on an enterprise-value basis.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—0.970.931.020.980.971.001.090.860.820.93
EV / EBITDA11.8811.9711.4513.0410.7711.3613.5111.8213.569.6110.96
EV / EBIT16.7618.4118.2419.9416.1914.0918.7914.8418.5211.5913.73
EV / FCF—22.3317.7735.5424.4719.1718.4918.7819.1021.9019.84

HSIC Profitability

Margins and return-on-capital ratios measuring operating efficiency

Henry Schein, Inc. earns an operating margin of 5.7%. ROE of 8.3% is modest. ROIC of 7.1% represents adequate returns on invested capital.

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin29.1%29.1%29.7%29.6%28.9%29.6%27.8%31.0%22.0%27.3%27.9%
Operating Margin5.7%5.7%5.8%5.8%7.4%6.9%5.6%7.3%5.3%6.9%7.1%
Net Profit Margin3.0%3.0%3.1%3.4%4.3%5.0%4.0%5.1%4.1%3.3%4.4%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE8.3%8.3%7.8%8.5%11.5%13.9%9.8%13.1%14.3%11.5%14.8%
ROA3.7%3.7%3.8%4.3%6.3%7.7%5.4%6.5%6.5%5.6%7.6%
ROIC7.1%7.1%7.1%7.8%11.9%12.0%8.8%10.4%9.6%13.4%14.0%
ROCE9.8%9.8%9.5%10.0%14.9%14.7%10.7%14.1%13.4%18.3%18.6%

HSIC Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

Henry Schein, Inc. carries a Debt/EBITDA ratio of 3.4x, which is moderately leveraged (7% above the sector average of 3.2x). Net debt stands at $3.5B ($3.7B total debt minus $156M cash). Interest coverage of 4.6x is adequate, though a cyclical earnings downturn could tighten the margin of safety.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.770.770.590.530.320.260.230.250.500.460.36
Debt / EBITDA3.453.452.802.851.301.141.331.092.321.581.23
Net Debt / Equity—0.740.570.500.300.240.130.230.490.410.34
Net Debt / EBITDA3.303.302.682.671.201.030.770.972.251.411.17
Debt / FCF—6.164.167.282.731.741.061.543.173.212.12
Interest Coverage4.634.634.927.2317.3931.0913.0814.398.0616.3424.70

HSIC Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

A current ratio of 1.38x means Henry Schein, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 0.76x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 1.67x to 1.38x over the past 3 years.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio1.381.381.421.671.791.671.661.581.301.441.44
Quick Ratio0.760.760.781.000.910.861.000.880.860.760.72
Cash Ratio0.050.050.040.060.050.050.180.050.020.060.03
Asset Turnover—1.181.241.171.471.461.301.401.551.581.71
Inventory Turnover4.674.674.924.794.584.694.834.834.604.695.01
Days Sales Outstanding—45.7142.6855.1141.6242.7451.3945.5532.3144.6039.56

HSIC Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Henry Schein, Inc. returns 9.3% to shareholders annually primarily through share buybacks. The earnings yield of 4.1% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield4.1%4.3%4.3%4.2%4.9%5.7%4.2%5.1%5.7%4.7%5.2%
FCF Yield6.2%6.2%7.3%3.5%4.6%5.7%5.7%5.8%6.3%5.4%5.6%
Buyback Yield9.3%9.2%4.3%2.8%4.4%3.6%0.9%5.3%2.1%5.2%5.7%
Total Shareholder Yield9.3%9.2%4.3%2.8%4.4%3.6%0.9%5.3%2.1%5.2%5.7%
Shares Outstanding—$122M$128M$132M$138M$142M$143M$149M$154M$158M$162M

Peer Comparison

Compare HSIC with 10 similar companies in its peer group

CompanyMarket CapP/EEV/EBITDAP/FCFGross MarginOp MarginROEROICDebt/EBITDA
HSIC logoHSICYou$9B24.411.916.029.1%5.7%8.3%7.1%3.4
DXPE logoDXPE$3B32.415.649.931.5%8.8%19.3%12.5%4.6
OMI logoOMI$171M-0.21.7——1.0%-2111.6%1.8%2.6
MCK logoMCK$90B19.613.215.83.6%1.6%—254.1%1.2
CAH logoCAH$52B34.418.828.23.7%1.0%—3378.7%3.0
XRAY logoXRAY$2B-3.47.019.950.0%6.8%-36.4%5.1%4.1
ALGN logoALGN$13B32.215.226.668.3%15.3%10.4%15.4%0.1
NVST logoNVST$4B92.513.818.355.0%8.3%1.6%4.8%5.0
PRTS logoPRTS$51M-0.8——29.0%-8.3%-72.8%-39.3%—
GMED logoGMED$11B20.217.118.167.4%16.3%12.3%8.9%0.2
SYK logoSYK$118B36.621.227.564.0%19.5%15.1%11.4%2.4
Healthcare Median—22.114.218.563.9%-4.3%-32.6%-11.6%3.2

Peer selection based on competitive and market overlap. Compare multiple stocks →

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

HSIC — Frequently Asked Questions

Quick answers to the most common questions about buying HSIC stock.

What is Henry Schein, Inc.'s P/E ratio?

Henry Schein, Inc.'s current P/E ratio is 24.4x. The historical average is 21.3x. This places it at the 89th percentile of its historical range.

What is Henry Schein, Inc.'s EV/EBITDA?

Henry Schein, Inc.'s current EV/EBITDA is 11.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 14.0x.

What is Henry Schein, Inc.'s ROE?

Henry Schein, Inc.'s return on equity (ROE) is 8.3%. The historical average is 11.6%.

Is HSIC stock overvalued?

Based on historical data, Henry Schein, Inc. is trading at a P/E of 24.4x. This is at the 89th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are Henry Schein, Inc.'s profit margins?

Henry Schein, Inc. has 29.1% gross margin and 5.7% operating margin.

How much debt does Henry Schein, Inc. have?

Henry Schein, Inc.'s Debt/EBITDA ratio is 3.4x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.